SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 14, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Insider cluster: 2 insiders, $794K total
Actionable Insight • Neutral

The insider selling is routine in both proportionality and pattern, CEO Rothblatt regularly exercises options and sells shares for liquidity. The cluster does not add incremental bearish information beyond the already-reported Q2 revenue miss. Monitor the next earnings call for Tyvaso DPI growth trajectory and ralinepag/nebulized Tyvaso IPF NDA updates as the real catalysts.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$508.48
T+0 close · Aug 14, 2026 · via day close
Latest settled
+15.76%
T+60 · $588.61
Vs SPY
+18.70%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $508.48entry
  2. T+1 · 3mo ago +1.93%α +2.60% · $518.27
  3. T+5 · 3mo ago +0.87%α +2.06% · $512.88
  4. T+20 · 2mo ago −1.60%α +0.38% · $500.35
  5. T+60 · 7d ago +15.76%α +18.70% · $588.61
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Martine Rothblatt sold ~$7.1M in open-market shares over two days (Aug 12-13), exercising options at $135.42 and immediately selling the shares near $500-$520. EVP Paul Mahon also sold $167K on Aug 6. The cluster follows a Q2 earnings miss (revenue -2% YoY, below consensus) reported 10 days prior. While the CEO's sales are partially option-exercise-related, the timing and magnitude, ~$7.1M from the CEO alone, or ~0.03% of market cap, are modest relative to the $21.4B market cap, making this a routine liquidity/compensation event rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$7.3M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$7.1M in open-market shares on Aug 12-13, exercising 28,500 options at $135.42 and selling the resulting shares at $500-$520.
  • EVP Paul Mahon sold 320 shares for $167K on Aug 6.
  • Total cluster value of ~$7.3M represents ~0.03% of UTHR's $21.4B market cap, well below the 0.1% materiality threshold.
  • The cluster follows Q2 2026 earnings (Aug 5) where revenue of $783.3M missed the $804.6M consensus, though EPS of $7.27 beat estimates.
  • CEO's sales are consistent with a typical option-exercise-and-sell pattern for tax/compensation purposes, not a directional bearish signal.

Financial Impact

CEO sold ~$7.1M in open-market shares; EVP sold $167K; total cluster ~$7.3M (0.03% of market cap)

insider ownershipdilution

Risk Factors

  • Continued Tyvaso franchise erosion (nebulized Tyvaso -18% YoY) could pressure revenue growth
  • Competitive headwinds in inhaled prostacyclin class may limit Tyvaso DPI market share gains
  • Pipeline setbacks for ralinepag or nebulized Tyvaso IPF could remove upside optionality

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1786774470943

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 15, 2026